Home › Trial NCT00854581
Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma
- Trial IDNCT00854581
- StatusTerminated
- PhasePhase 4
- Study typeInterventional
- SponsorUniversity of Miami
- Enrollment13
- Start date2007-11
- ConditionsLymphoma · Precancerous/Nonmalignant Condition
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.